Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Infections × Polymerase Chain Reaction × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 5 Leukemia 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Lymphoma 4 Congenital Abnormalities 4 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Carcinoma, Renal Cell 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Uterine Cervical Neoplasms 2 Rectal Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Extranodal NK-T-Cell 2 Lung Neoplasms 2 Leukemia, Myeloid, Accelerated Phase 2 Kidney Neoplasms 2 Hodgkin Disease 2 Head and Neck Neoplasms 2 HIV Infections 2

Interventions

Daptomycin 2 threonic acid 1 telavancin 1 telaprevir 1 soybean oil, phospholipid emulsion 1 plerixafor 1 peginterferon alfa-2a 1 human papillomavirus vaccine, L1 type 16, 18 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Voriconazole 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Trimethoprim 1 Tacrolimus 1 Sulfamethoxazole 1 Sirolimus 1 Ribavirin 1 Peripheral Blood Stem Cell Transplantation 1 Ofloxacin 1 Methotrexate 1 Melphalan 1 Magnesium Sulfate 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Fluconazole 1 Filgrastim 1 Etoposide 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡